Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid(TM) liquid embolic agent. Squid is approved for the embolization of the ...
Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squidâ„¢ liquid embolic agent. Squid is approved for the embolization of the middle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results